PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17219718-8	2006	IGF-I was present in AL of all tested groups.	Aluminum	21-23	insulin like growth factor 1	Homo sapiens	0-5	
29044624-6	2018	There was a significant decrease in IGF-1 in plasma and IRS-1 protein content in muscle of AL group.	Aluminum	91-93	insulin like growth factor 1	Homo sapiens	36-41	
19340002-3	2009	We demonstrated that AL-derived BMSC secreted more insulin growth factor-1 (IGF-1) and SDF-1alpha than controls.	Aluminum	21-23	insulin like growth factor 1	Homo sapiens	51-74	
19340002-3	2009	We demonstrated that AL-derived BMSC secreted more insulin growth factor-1 (IGF-1) and SDF-1alpha than controls.	Aluminum	21-23	insulin like growth factor 1	Homo sapiens	76-81	
19340002-6	2009	In normal BMSC, addition of exogenous IGF-1 generated capillary-like tubes through the same pathway as observed spontaneously in AL-derived BMSC.	Aluminum	129-131	insulin like growth factor 1	Homo sapiens	38-43	
17219718-9	2006	The number of IGF-I positive AL was significantly higher in IPF (52 +/- 6.7%) and in later (II and III) stages of sarcoidosis (39 +/- 7.8 vs 16 +/- 4.0% in controls, p < 0.05).	Aluminum	29-31	insulin like growth factor 1	Homo sapiens	14-19	
17219718-13	2006	Proportion of AL positive for IGF-I was significantly correlated with parameters reflecting AL and AM cell proliferation and BCL-2 expression (e.g. AL IGF-I+ vs AM in S phase of cell cycle: r(S) = +0.50, p = 0.001), but not with apoptosis.	Aluminum	14-16	insulin like growth factor 1	Homo sapiens	30-35	
17219718-13	2006	Proportion of AL positive for IGF-I was significantly correlated with parameters reflecting AL and AM cell proliferation and BCL-2 expression (e.g. AL IGF-I+ vs AM in S phase of cell cycle: r(S) = +0.50, p = 0.001), but not with apoptosis.	Aluminum	14-16	insulin like growth factor 1	Homo sapiens	151-156	
17219718-13	2006	Proportion of AL positive for IGF-I was significantly correlated with parameters reflecting AL and AM cell proliferation and BCL-2 expression (e.g. AL IGF-I+ vs AM in S phase of cell cycle: r(S) = +0.50, p = 0.001), but not with apoptosis.	Aluminum	92-94	insulin like growth factor 1	Homo sapiens	30-35	
17219718-17	2006	We suggest that IGF-I originating from AL may be locally active as a mitogen for alveolar macrophages and lymphocytes in ILD.	Aluminum	39-41	insulin like growth factor 1	Homo sapiens	16-21	
7685579-4	1993	The effect of aluminum ion on the steady-state level of IGF-I mRNA could not be determined since the IGF-I mRNA in these cells was not detectable with our oligodeoxynucleotide probes.	Aluminum	14-22	insulin like growth factor 1	Homo sapiens	56-61	
17288168-9	2006	Decreased IGF-I expression in AL of sarcoidosis smokers was observed (13.5 +/- 9.2 vs 46.0 +/- 6.0 in nonsmokers, p < 0.05).	Aluminum	30-32	insulin like growth factor 1	Homo sapiens	10-15